Compounds > threonine

threonine and Central Nervous System Neoplasm

threonine has been researched along with Central Nervous System Neoplasm in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bagó, AG; Bödör, C; Csala, I; Deák, B; Hajdu, M; Kriston, C; Marosvári, D; Nagy, N; Reiniger, L; Sebestyén, A; Szállási, Z1
Bocchia, M; Brambilla, CZ; Candi, V; Gozzetti, A; Papini, G; Sirianni, S1

Reviews

1 review(s) available for threonine and Central Nervous System Neoplasm

ArticleYear
Second Generation Proteasome Inhibitors in Multiple Myeloma.
    Anti-cancer agents in medicinal chemistry, 2017, Volume: 17, Issue:7

    Topics: Animals; Boronic Acids; Bortezomib; Central Nervous System Neoplasms; Drug Discovery; Humans; Lactones; Multiple Myeloma; Neoplasm Recurrence, Local; Oligopeptides; Proteasome Inhibitors; Pyrroles; Threonine

2017

Other Studies

1 other study(ies) available for threonine and Central Nervous System Neoplasm

ArticleYear
Discrepancy Between Low Levels of mTOR Activity and High Levels of P-S6 in Primary Central Nervous System Lymphoma May Be Explained by PAS Domain-Containing Serine/Threonine-Protein Kinase-Mediated Phosphorylation.
    Journal of neuropathology and experimental neurology, 2018, 04-01, Volume: 77, Issue:4

    Topics: Cell Line, Tumor; Central Nervous System Neoplasms; Chi-Square Distribution; Female; Humans; Lymphoma; Male; Phosphorylation; Protein Serine-Threonine Kinases; Ribosomal Protein S6 Kinases; Serine; Signal Transduction; Threonine; TOR Serine-Threonine Kinases

2018